Affecting factors on diffusion area of Botulinum toxin type A

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046507

Enrollment

Unknown

Registered

2021-05-18

Start date

2020-05-01

Completion date

Unknown

Last updated

2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffusion of Botulinum toxin A

Interventions

four injection groups:four groups of injection points on the chest and back, from left to right: high-concentration low-volume high-speed injection, high-concentration low-volume low-speed injection,

Eligibility

Sex/Gender

All

Age

35 Years to 41 Years

Inclusion criteria

Inclusion criteria: Aged 18 years, in line with minimally invasive surgery indicators, all patients have informed consent and voluntarily receive minimally invasive injection treatment.

Exclusion criteria

Exclusion criteria: Any BoNTA or hyaluronic acid injection within 1 year, bleeding disorders, allergy to iodine, any thorax or back deformity, and infection or trauma in the injection.

Design outcomes

Primary

Measure	Time frame
diffusion area;	—

Secondary

Measure	Time frame
dermic thickness;	—

Countries

China

Contacts

Public ContactYu Nanze

Peking Union Medical College

yunanze@163.com+86 15910522916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026